A popular FDA-approved drug to treat hypertension, hydralazine works, at least in part, by modulating RGS proteins! Honored to be a part of a collaborative team led by @MegaMatthewsLab!
biorxiv.org/content/10.110…

1/14 Our latest study just out on BioRxiv [biorxiv.org/content/10.110…] has unusual personal significance for me. It connects two apparently unrelated diseases – (pre)eclampsia and glioblastoma – that have both impacted my family.

14/14 We are extremely excited to leverage these new findings for (pre)eclampsia and glioblastoma drug development, and we are actively seeking investors and partners for our company, Zenagem, LLC, to move forward.

@PennChemistry, @PennMedicine, @biorxivpreprint, @BrainCancerCtr, @WHO, @CovalentMod

I’m speaking at ‘Emergence of irreversible modulation in drug discovery’ on 16-17 October 2024! Join us in Cambridge where we will bring together established leaders and emerging investigators exploring irreversible covalent modulators. Register now: ow.ly/iVIl50QwiKs”

Our annual awards ceremony was a blast! Congrats to all of the recipients.

Calling people "toxic" is rarely helpful. It focuses on their impact instead of their actions.

Toxicity comes in 5 flavors: disrespectful, dishonest, cutthroat, exclusionary, and abusive.

A good warning pinpoints patterns of behavior that are problematic and persistent.
r

wsj.com/health/wellnes…

Awesome talk by Prof. Will Parsons today on ABPP!!!! Great work done by Oberlin undergrads and Penn grads!